Bill > HCR010

This concurrent resolution directs the Public Employees' Benefit and Insurance Program (PEHP), which provides insurance for state employees, to include hormone replacement therapy (HRT) treatments in its drug formulary to alleviate symptoms associated with perimenopause and menopause. The resolution acknowledges that menopause is a natural aging process for women characterized by a decline in reproductive hormones, leading to various symptoms like hot flashes, sleep disturbances, and emotional changes. It highlights that access to effective treatment can be hindered by factors such as a lack of provider knowledge and stigma, and notes that recent studies and FDA actions indicate HRT is a safe and effective treatment for these symptoms, involving the restoration of estrogen and progesterone.